Combilytics Corp is a biopharma and biotechnology startup based in Canada. Founded in 2020, the company's mission is outlined in its slogan: "Providing an effective natural senolytic solution today." The company is dedicated to the exploration and provision of the latest science-based information and therapeutic compounds to enhance the health span of its clients. Combilytics Corp markets natural compounds that have been proven to support anti-aging functions and utilizes a data-driven client support system to stay at the forefront of understanding what is effective in anti-aging products. The company recently secured a $250.00K Pre Seed Round investment on 28 April 2022 from Newchip Accelerator. This capital injection is expected to fuel the company's research and development efforts, as well as its market expansion and client support infrastructure. With its focus on leveraging natural compounds and data-driven insights, Combilytics Corp stands poised to make significant strides in the anti-aging market.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Pre Seed Round | $250.00K | 1 | Newchip Accelerator | 28 Apr 2022 |
No recent news or press coverage available for Combilytics Corp.